Oxytocin deficiency in patients with arginine vasopressin deficiency (central diabetes insipidus)

Affiliations

¹ Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France; Endocrinology Department, "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania.
² Endocrinology Department, "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, 69677 Bron, France. Electronic address: gerald.raverot@chu-lyon.fr.

Comment

Mirela Diana Ilie et al. Lancet Diabetes Endocrinol. 2023 Jul.

. 2023 Jul;11(7):442-443.

doi: 10.1016/S2213-8587(23)00126-2. Epub 2023 May 13.

¹ Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France; Endocrinology Department, "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania.
² Endocrinology Department, "C.I. Parhon" National Institute of Endocrinology, Bucharest, Romania; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, 69677 Bron, France. Electronic address: gerald.raverot@chu-lyon.fr.

No abstract available

Conflict of interest statement

We declare no competing interests.

Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Atila C, Holze F, Murugesu R, Rommers N, Hutter N, Varghese N, Sailer CO, Eckert A, Heinrichs M, Liechti ME, Christ-Crain M. Atila C, et al. Lancet Diabetes Endocrinol. 2023 Jul;11(7):454-464. doi: 10.1016/S2213-8587(23)00120-1. Epub 2023 May 13. Lancet Diabetes Endocrinol. 2023. PMID: 37192642 Clinical Trial.